Citation Tools
PDFRegular and Young Investigator Award Abstracts
Cell Therapies
275 Manufacture of allogeneic, HLA-matched, TCR-edited T-cell therapy reactive against minor histocompatibility antigen 1 to treat acute myeloid leukemia in combination with CD34 HSCT with the potential for high potency and durability
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 275 Manufacture of allogeneic, HLA-matched, TCR-edited T-cell therapy reactive against minor histocompatibility antigen 1 to treat acute myeloid leukemia in combination with CD34 HSCT with the potential for high potency and durability